MERSİN UNIVERSITY HOSPITAL
Slide background
Corporate

Department of Infectious Diseases


Publications in International Scientific Journals(last two years)

2022
9. Karaşahin, .; Akdemir kalkan, .; Dal, T.; Kömür, S.; Yıldız, Y.; Kandemir, .; çelen, M. . HEPATITIS MONTHLY, 2022, , -.
2021
8. Ersöz, G. . MIKROBIYOLOJI BULTENI, 2021, 55, -.
10.5578/mb.20219904
7. Gülbudak, H.; Karvar, .; Soydan, G.; Tezcan ülger, S.; Kandemir, .; Aslan, G. . MIKROBIYOLOJI BULTENI, 2021, , -.
2020
6. Ersöz, G. . BALKAN MEDICAL JOURNAL, 2020, 37, 125-130.
10.4274/balkanmedj.galenos.2020.2019.5.89
5. Ersöz, G. . JOURNAL OF CHEMOTHERAPY, 2020, 32, 188-192.
10.1080/1120009X.2020.1755592
4. Böğrekci, G.; çetinkaya, A.; Kandemir, F.; Bekalp yılmaz, .; Orekici temel, G.; Aras, N. . MIKROBIYOLOJI BULTENI, 2020, 54, 279-290.
3. Kandemir, F.; şahinoğlu, M.; şahin horosan, E. . BALKAN MEDICAL JOURNAL, 2020, 37, 299-300.
10.4274/balkanmedj.galenos.2020.2019.11.70. Epub 2020 Mar 25.
2. Aygen, B.; Demirturk, N.; Yildiz, O.; Celen, M.; Celik, I.; Barut, S.; Ural, O.; Batirel, A. Real-world efficacy, safety, and clinical outcomes of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin combination therapy in patients with hepatitis C virus genotype 1 or 4 infection: The Turkey experience experience. AVES PUBLISHING CO., 2020, 31, 305-317.
http://dx.doi.org/10.5152/TJG.2020.19197
1. Ersöz, G. . INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 95, 84-89.
10.1016/j.ijid.2020.03.061